Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
For the treatment-regimen estimand, the mean body weight reductions from baseline at 72 weeks were 15.0%, 19.5%, and 20.9% in the tirzepatide 5, 10, and 15 mg groups, respectively, versus 3.1% in the placebo group
By activating both GIP and GLP-1 receptors, Tirzepatide influences multiple pathways that affect metabolism, helping improve energy balance and body composition
Keeping blood sugar stable Hypoglycaemia (low blood sugar) is a recognised seizure trigger
Weight loss typically becomes noticeable between weeks 4 and 8 as your body adapts to reduced appetite and improved satiety
US$ 25.37
US$ 21.91
US$ 24.51
US$ 25.67
US$ 29.33
US$ 22.58
